In silico studies on Acalypha indica, Catharanthus roseus and Coleus aromaticus derivative compounds against omicron
by Selvaraj Radhathirumalaiarasu
International Journal of Bioinformatics Research and Applications (IJBRA), Vol. 19, No. 2, 2023

Abstract: The omicron, a variant of the corona virus has a high rate of transmissibility, lower vaccine efficiency and exhibit increase risk of reinfection. There is an urgent need for suitable medicine replacing synthetic drug to avoid side effects. Molecular docking tool was used to analyse the binding ability of natural and synthetic compounds with the target omicron protein (7TL9). ADME and bioactivity score were performed to evaluate drug likeness properties. The phytochemicals like mannoside from Catharanthus roseus has a score value (-9.8 kcal/mol), while salviaflaside from Coleus aromaticus shows score value (-9.6 kcal/mol). The drug remdesivir (-8.4 kcal/mol) had demonstrated a low binding energy compared with acaindinin, which has a high score value (-10 kcal/mol). Acaindinin from Acalypha indica reveals the highest binding energy compared to the other phytochemicals retrieved. Further the excellent ADME property and bioactivity scores confirm its efficacy as a suitable drug for treating omicron.

Online publication date: Mon, 31-Jul-2023

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Bioinformatics Research and Applications (IJBRA):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com